Related Experiment Video
Updated: Oct 13, 2025
A Genetic Screen to Isolate Toxoplasma gondii Host-cell Egress Mutants
Published on: February 8, 2012
Pediatric hypereosinophilia and toxoplasma: Peregrination beyond facileness
Aaqib Z Banday1, Dharmagat Bhattarai1, Naveen Bhagat1
1Allergy Immunology Unit, Departments of Pediatrics, Advanced Pediatrics Centre, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
Insights
Pediatric hypereosinophilia (HE) diagnosis is difficult in developing countries due to limited resources and common infections. Long-term follow-up is crucial as multiple causes may contribute to severe HE.
Area of Science:
- Pediatric Hematology
- Tropical Medicine
- Infectious Diseases
Background:
- Evaluating pediatric hypereosinophilia (HE) presents significant challenges in tropical developing countries.
- Limited diagnostic facilities, high prevalence of parasitic/helminthic infections, and sparse etiological data complicate HE assessment.
- Lack of long-term follow-up data hinders understanding the temporal course and potential multiple etiologies of severe HE.
Observation:
- A real-life clinical case illustrates the diagnostic and therapeutic dilemmas associated with pediatric HE.
- The case highlights the potential for HE to result from a combination of underlying causes rather than a single etiology.
- An unusual association between severe eosinophilia and toxoplasmosis was observed in a pediatric patient.
Findings:
- Severe pediatric hypereosinophilia can be multifactorial, necessitating comprehensive diagnostic approaches.
- The study successfully treated a case of severe eosinophilia associated with toxoplasmosis.
- An 8-week combination therapy of azithromycin and cotrimoxazole proved effective in managing the condition.
Implications:
- Emphasizes the critical need for long-term follow-up in pediatric HE cases to identify combinatorial etiologies.
- Suggests that integrated diagnostic and therapeutic strategies are essential for managing complex pediatric HE cases in resource-limited settings.
- Provides evidence for successful treatment of toxoplasmosis-associated severe eosinophilia using azithromycin and cotrimoxazole.
Abstract:
Evaluation of pediatric hypereosinophilia (HE) is challenging, especially in the tropical developing countries, as appropriate diagnostic facilities may be lacking, parasitic/helminthic infections are common, and existing data on the etiology of severe eosinophilia are sparse. Second, data on long-term follow-up of these children including the temporal course of eosinophilia are also scarce. Besides, questions regarding the coexistence of multiple etiologies and their association with the severity of HE are largely unexplored. These challenges and questions often lead to diagnostic and therapeutic dilemmas. We highlight these difficulties utilizing a real-life clinical description. We emphasize the need for long-term follow-up of such children as HE may be the combinatorial effect of multiple etiologies, rather than a single cause. We also describe an unusual association of severe eosinophilia in a child with toxoplasmosis that was treated successfully with 8-week combination therapy with azithromycin and cotrimoxazole (sulfadiazine and pyrimethamine were not available).
Related Concept Videos
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion